The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial.

Trials · 2011 · PMC3247852 · PMID 22108275

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The CHIPS trial [ 20 ] compared low-dose (50 mg/day) with high-dose (100 mg/day) captopril therapy and demonstrated a nonsignificant trend toward less worsening heart failure and hospitalization in the high-dose group.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.